Deerfield-Management-Company-Lp-Series-C

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
123
Total Value
5064779427
Accession Number
0001213900-25-044138
Form Type
13F-HR
Manager Name
Deerfield-Management-Company-Lp-Series-C
Data Enrichment
87% identified
107 identified16 unidentified

Holdings

123 positions
Manager:
Search and click to pin securities to the top
10x Genomics, Inc.
Shares:1.5M
Value:$13.1M
Pulmonx Corp
Shares:1.9M
Value:$12.7M
08659B102
Shares:1.0M
Value:$12.4M
Zenas BioPharma, Inc.
Shares:1.6M
Value:$12.3M
Foghorn Therapeutics Inc.
Shares:3.3M
Value:$11.9M
NovoCure Ltd
Shares:650.1K
Value:$11.6M
OPKO HEALTH, INC.
Shares:6.9M
Value:$11.5M
DELCATH SYSTEMS, INC.
Shares:813.1K
Value:$10.4M
GH Research PLC
Shares:925.0K
Value:$10.2M
RxSight, Inc.
Shares:392.3K
Value:$9.9M
Simulations Plus, Inc.
Shares:354.1K
Value:$8.7M
Dyne Therapeutics, Inc.
Shares:812.4K
Value:$8.5M
Vaxcyte, Inc.
Shares:225.0K
Value:$8.5M
829401108
Shares:747.0K
Value:$7.8M
Spyre Therapeutics, Inc.
Shares:450.0K
Value:$7.3M
Structure Therapeutics Inc.
Shares:373.4K
Value:$6.5M
NeuroPace Inc
Shares:500.0K
Value:$6.1M
Perspective Therapeutics, Inc.
Shares:2.8M
Value:$6.0M
Neurogene Inc.
Shares:446.9K
Value:$5.2M
Oncology Institute, Inc.
Shares:3.4M
Value:$3.8M